Shares of Lakeshore Biopharma Co., Ltd. (NASDAQ:LSB – Get Free Report) gapped down prior to trading on Friday . The stock had previously closed at $6.82, but opened at $5.11. Lakeshore Biopharma shares last traded at $5.46, with a volume of 30,145 shares trading hands.
Lakeshore Biopharma Trading Down 22.1 %
The company has a current ratio of 1.13, a quick ratio of 0.87 and a debt-to-equity ratio of 0.17. The business’s 50-day moving average is $0.54.
Lakeshore Biopharma Company Profile
LakeShore Biopharma Co, Ltd, a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001.
Read More
- Five stocks we like better than Lakeshore Biopharma
- Utilities Stocks Explained – How and Why to Invest in Utilities
- The Outlook for Interest Rate Cuts Got Blown Out of the Water
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- 3 High-Risk, High-Reward Micro-Cap Stocks You Shouldn’t Ignore
- How to Use the MarketBeat Stock Screener
- 3 Bargain Stocks Positioned for Gains After Missing 2024’s Rally
Receive News & Ratings for Lakeshore Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lakeshore Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
